Advanced Search

Study Preview



Study Title and Description

Tamoxifen and mammographic breast densities.



Key Questions Addressed
3 Key Question 3. What are the harms of using medications to reduce risk for primary breast cancer? Key Question 3a. Do harms of risk-reducing medications vary by timing of initiation and/or duration of use? Key Question 3b. Do harms of risk-reducing medications persist beyond discontinuation of use?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Tamoxifen and mammographic breast densities.
Author Brisson J., Brisson B., Coté G., Maunsell E., Bérubé S., Robert J.
Country Epidemiology Research Group, Saint-Sacrement Hospital CHA, Quebec City, Quebec, Canada.
Year 2000
Numbers Pubmed ID: 11008908

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Key Questions 1-4


Results & Comparisons

No Results found.